
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated January 31, 2025, titled "CuraTeQ Biologics s.r.o, receives positive opinion from CHMP / EMA for Dyrupeg".
Filed with NSE ·

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated January 31, 2025, titled "CuraTeQ Biologics s.r.o, receives positive opinion from CHMP / EMA for Dyrupeg".
6ix hasn’t read this filing yet.
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma